Prime Capital Investment Advisors, LLC Invitae Corp Transaction History

Prime Capital Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$1.05 - $1.63 $6,111 - $9,486	5,820 Added 21.83%	32,475 $36,000
Q1 2023 May 05, 2023	BUY	$1.2 - $2.73 $31,986 - $72,768	26,655 New	26,655 $35,000
Q2 2021 Aug 12, 2021	SELL	$26.09 - $40.4 $15,549 - $24,078	-596 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$33.06 - $56.93 $12,199 - $21,007	369 Added 162.56%	596 $23,000
Q4 2020 Feb 03, 2021	BUY	$39.09 - $57.4 $8,873 - $13,029	227 New	227 $9,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.